Thermo Fisher Scientific Inc.
NYSE-TMO
Basic
Market Cap
$217.09B
EV
$245.57B
Shares Out
381.71M
Revenue
$42.49B
Employees
122,000
Margins
Gross
40.29%
EBITDA
25.37%
Operating
17.41%
Pre-Tax
15.33%
Net
14.2%
FCF
17.79%
Returns (5Yr Avg)
ROA
8.19%
ROTA
29.41%
ROE
16.77%
ROCE
11.65%
ROIC
10.93%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$623.11
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$7,250M
Net Debt
$28.36B
Debt/Equity
0.78
EBIT/Interest
5.14
Growth (CAGR)
Rev 3Yr
5.79%
Rev 5Yr
11.52%
Rev 10Yr
11.9%
Dil EPS 3Yr
-7.76%
Dil EPS 5Yr
14.78%
Dil EPS 10Yr
14.72%
Rev Fwd 2Yr
3.75%
EBITDA Fwd 2Yr
4.41%
EPS Fwd 2Yr
6.41%
EPS LT Growth Est
9.68%
Dividends
Yield
—
Payout
9.19%
DPS
$1.44
DPS Growth 3Yr
16.11%
DPS Growth 5Yr
15.52%
DPS Growth 10Yr
9.15%
DPS Growth Fwd 2Yr
9.54%
Select a metric from the list below to chart it
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM
Dec '24 (E)
Dec '25 (E)
Dec '26 (E)